Baker Bros. Advisors as of March 31, 2017
Portfolio Holdings for Baker Bros. Advisors
Baker Bros. Advisors holds 119 positions in its portfolio as reported in the March 2017 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Incyte Corporation (INCY) | 37.3 | $4.6B | 34M | 133.67 | |
Seattle Genetics | 23.5 | $2.9B | 46M | 62.86 | |
ACADIA Pharmaceuticals (ACAD) | 7.3 | $888M | 26M | 34.38 | |
Alexion Pharmaceuticals | 6.5 | $793M | 6.5M | 121.24 | |
Genomic Health | 3.5 | $434M | 14M | 31.49 | |
BioMarin Pharmaceutical (BMRN) | 3.5 | $422M | 4.8M | 87.78 | |
Dbv Technologies S A | 1.6 | $194M | 5.5M | 35.22 | |
Aquinox Pharmaceuticals | 1.5 | $183M | 11M | 16.69 | |
Beigene | 1.1 | $135M | 3.7M | 36.61 | |
Achaogen | 0.9 | $116M | 4.6M | 25.23 | |
BioCryst Pharmaceuticals (BCRX) | 0.8 | $98M | 12M | 8.40 | |
Biomarin Pharmaceutical Inc note 1.875% 4/2 | 0.8 | $96M | 22M | 4.29 | |
Advanced Accelerat spon ads each rep 2 ord | 0.7 | $89M | 2.2M | 39.86 | |
Invitae (NVTAQ) | 0.7 | $81M | 7.3M | 11.06 | |
Amarin Corporation (AMRN) | 0.6 | $73M | 23M | 3.20 | |
Spark Therapeutics | 0.6 | $70M | 1.3M | 53.34 | |
Acorda Therapeutics | 0.6 | $69M | 3.3M | 21.00 | |
Bellicum Pharma | 0.5 | $62M | 5.0M | 12.34 | |
Cerus Corporation (CERS) | 0.5 | $58M | 13M | 4.45 | |
Exelixis (EXEL) | 0.5 | $56M | 2.6M | 21.67 | |
Novavax Inc note 3.750% 2/0 | 0.4 | $49M | 109M | 0.45 | |
Heron Therapeutics (HRTX) | 0.3 | $42M | 2.8M | 15.00 | |
Neurocrine Biosciences (NBIX) | 0.3 | $39M | 895k | 43.30 | |
Ascendis Pharma A S (ASND) | 0.3 | $38M | 1.4M | 28.00 | |
Avexis | 0.3 | $38M | 500k | 76.03 | |
Versartis | 0.3 | $36M | 1.7M | 21.35 | |
Bluebird Bio (BLUE) | 0.3 | $32M | 351k | 90.90 | |
Progenics Pharmaceuticals | 0.2 | $30M | 3.2M | 9.44 | |
Acorda Therap note 1.75% 6/15 | 0.2 | $30M | 35M | 0.85 | |
Merus N V (MRUS) | 0.2 | $28M | 1.2M | 24.39 | |
Idera Pharmaceuticals | 0.2 | $25M | 10M | 2.47 | |
Sangamo Biosciences (SGMO) | 0.2 | $24M | 4.5M | 5.20 | |
Galapagos Nv- (GLPG) | 0.2 | $22M | 260k | 86.19 | |
Xencor (XNCR) | 0.2 | $21M | 872k | 23.92 | |
Halozyme Therapeutics (HALO) | 0.1 | $18M | 1.4M | 12.96 | |
Array BioPharma | 0.1 | $14M | 1.6M | 8.94 | |
Sage Therapeutics (SAGE) | 0.1 | $15M | 208k | 71.07 | |
Neuroderm Ltd F | 0.1 | $15M | 572k | 26.55 | |
Dermira | 0.1 | $14M | 415k | 34.11 | |
Aimmune Therapeutics | 0.1 | $15M | 674k | 21.73 | |
Intellia Therapeutics (NTLA) | 0.1 | $15M | 1.1M | 14.09 | |
Aerie Pharmaceuticals | 0.1 | $14M | 299k | 45.35 | |
Biomarin Pharmaceutical Inc note 0.750%10/1 | 0.1 | $14M | 12M | 1.13 | |
Aegerion Pharmaceuticals 2% Du cvbond | 0.1 | $13M | 17M | 0.80 | |
ImmunoGen | 0.1 | $12M | 3.0M | 3.87 | |
Mirati Therapeutics | 0.1 | $12M | 2.3M | 5.20 | |
Foamix Pharmaceuticals | 0.1 | $12M | 2.5M | 4.95 | |
La Jolla Pharmaceuticl Com Par | 0.1 | $11M | 379k | 29.85 | |
Catalyst Pharmaceutical Partners (CPRX) | 0.1 | $9.9M | 5.1M | 1.95 | |
Intra Cellular Therapies (ITCI) | 0.1 | $9.9M | 609k | 16.25 | |
Rigel Pharmaceuticals | 0.1 | $8.3M | 2.5M | 3.31 | |
Alkermes (ALKS) | 0.1 | $8.8M | 150k | 58.50 | |
Abeona Therapeutics | 0.1 | $8.4M | 1.7M | 5.00 | |
Achillion Pharmaceuticals | 0.1 | $7.8M | 1.9M | 4.21 | |
Ligand Pharmaceuticals In (LGND) | 0.1 | $7.8M | 73k | 105.84 | |
Insmed (INSM) | 0.1 | $7.0M | 400k | 17.51 | |
Agios Pharmaceuticals (AGIO) | 0.1 | $7.5M | 129k | 58.40 | |
Macrogenics (MGNX) | 0.1 | $6.8M | 364k | 18.60 | |
Contrafect | 0.1 | $7.3M | 4.0M | 1.80 | |
Loxo Oncology | 0.1 | $5.8M | 138k | 42.08 | |
Cymabay Therapeutics | 0.1 | $6.1M | 1.4M | 4.30 | |
Assembly Biosciences | 0.1 | $6.4M | 250k | 25.49 | |
Akari Therapeutics | 0.1 | $5.5M | 497k | 11.07 | |
Biogen Idec (BIIB) | 0.0 | $4.5M | 17k | 273.39 | |
D Stemline Therapeutics | 0.0 | $5.4M | 634k | 8.55 | |
Ignyta | 0.0 | $4.9M | 571k | 8.60 | |
Alder Biopharmaceuticals | 0.0 | $4.5M | 217k | 20.80 | |
Epizyme | 0.0 | $4.0M | 233k | 17.15 | |
Array Biopharma Inc note 3.000% 6/0 | 0.0 | $4.3M | 3.0M | 1.42 | |
Ultragenyx Pharmaceutical (RARE) | 0.0 | $3.4M | 50k | 67.78 | |
Trevena | 0.0 | $3.1M | 857k | 3.67 | |
Zogenix | 0.0 | $4.1M | 382k | 10.85 | |
Nabriva Therapeutics | 0.0 | $4.2M | 350k | 12.00 | |
Syros Pharmaceuticals | 0.0 | $3.3M | 205k | 15.93 | |
Ra Pharmaceuticals | 0.0 | $3.8M | 178k | 21.29 | |
Anaptysbio Inc Common (ANAB) | 0.0 | $4.2M | 150k | 27.75 | |
Infinity Pharmaceuticals (INFIQ) | 0.0 | $1.9M | 580k | 3.23 | |
Karyopharm Therapeutics (KPTI) | 0.0 | $2.8M | 217k | 12.84 | |
Glycomimetics (GLYC) | 0.0 | $2.1M | 381k | 5.43 | |
Adamas Pharmaceuticals | 0.0 | $3.0M | 173k | 17.50 | |
Protalix Biotherapeutics Inc note 4.500% 9/1 | 0.0 | $2.5M | 3.4M | 0.74 | |
Trillium Therapeutics, Inc. Cmn | 0.0 | $2.5M | 414k | 6.15 | |
Natera (NTRA) | 0.0 | $2.0M | 229k | 8.87 | |
Dimension Therapeutics | 0.0 | $2.2M | 1.3M | 1.75 | |
Selecta Biosciences | 0.0 | $2.5M | 176k | 14.32 | |
Spring Bk Pharmaceuticals In | 0.0 | $2.0M | 219k | 8.90 | |
Sunesis Pharmaceuticals Inc Ne | 0.0 | $3.0M | 742k | 4.10 | |
Inotek Pharmaceuticals 5.75% Cb 08/01/2021-registe bond | 0.0 | $3.0M | 5.0M | 0.60 | |
Aevi Genomic | 0.0 | $3.0M | 1.6M | 1.86 | |
Tonix Pharmaceuticals Hldg C | 0.0 | $2.1M | 450k | 4.67 | |
Jounce Therapeutics | 0.0 | $2.2M | 100k | 21.99 | |
Palatin Technologies | 0.0 | $677k | 2.1M | 0.33 | |
Chimerix (CMRX) | 0.0 | $735k | 115k | 6.38 | |
Acceleron Pharma | 0.0 | $761k | 29k | 26.46 | |
Five Prime Therapeutics | 0.0 | $696k | 19k | 36.16 | |
Mediwound Ltd cmn | 0.0 | $1.5M | 226k | 6.60 | |
Immune Design | 0.0 | $1.0M | 149k | 6.80 | |
Affimed Therapeutics B V | 0.0 | $920k | 400k | 2.30 | |
Juno Therapeutics | 0.0 | $1.1M | 50k | 22.20 | |
Cellectis S A (CLLS) | 0.0 | $1.2M | 50k | 24.00 | |
Invivo Therapeutics Hldgs | 0.0 | $1.6M | 400k | 4.05 | |
Seres Therapeutics (MCRB) | 0.0 | $1.4M | 125k | 11.27 | |
Corbus Pharmaceuticals Hldgs | 0.0 | $1.1M | 130k | 8.25 | |
Myokardia | 0.0 | $1.3M | 100k | 13.15 | |
Aeglea Biotherapeutics | 0.0 | $1.4M | 190k | 7.45 | |
Madrigal Pharmaceuticals (MDGL) | 0.0 | $890k | 58k | 15.41 | |
Fulgent Genetics (FLGT) | 0.0 | $1.4M | 125k | 10.92 | |
BioDelivery Sciences International | 0.0 | $399k | 210k | 1.90 | |
Cyclacel Pharmaceuticals Inc pfd conv ex 6% (CYCCP) | 0.0 | $83k | 13k | 6.26 | |
Chemocentryx | 0.0 | $357k | 49k | 7.28 | |
Dynavax Technologies (DVAX) | 0.0 | $446k | 75k | 5.95 | |
Proteon Therapeutics | 0.0 | $523k | 299k | 1.75 | |
Biotime Inc wts oct 1 18 | 0.0 | $12k | 20k | 0.60 | |
Biopharmx | 0.0 | $192k | 377k | 0.51 | |
Adaptimmune Therapeutics (ADAP) | 0.0 | $551k | 100k | 5.51 | |
Arbutus Biopharma (ABUS) | 0.0 | $587k | 181k | 3.25 | |
Ritter Pharmaceuticals | 0.0 | $568k | 400k | 1.42 | |
Windtree Therapeutics | 0.0 | $291k | 255k | 1.14 | |
Bioverativ Inc Com equity | 0.0 | $449k | 8.2k | 54.43 |